Quarterly report pursuant to Section 13 or 15(d)

Summary of Significant Accounting Policies (Details) - Schedule of anti dilutive common shares

v3.22.2
Summary of Significant Accounting Policies (Details) - Schedule of anti dilutive common shares - shares
3 Months Ended 6 Months Ended
Jun. 30, 2022
Jun. 30, 2021
Jun. 30, 2022
Jun. 30, 2021
Schedule of anti dilutive common shares [Abstract]        
Options 3,259,121 3,259,121 1,630,000
Warrants 11,153,908 6,001,250 11,153,908 8,628,908
Convertible debt [1] 63,425 63,425
Total potentially dilutive shares 14,413,029 6,064,675 14,413,029 10,322,333
[1] Represents shares issuable upon conversion of debt at various conversion prices, some of which were calculated using the fair value of the Company’s common stock at the respective balance sheet date.